Monica Torres, MD
Pain Medicine · Scottsdale, AZNPI 1740461672
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,392 of the $8,486 with a category attached, or 87.1%. It is spread thinly across 42 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $3,756 and has fallen 72.2% since, to $1,043 in 2025.
Across 261 payments — averaging $32.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- AbbVie$765
- Nalu Medical, Inc.$748
- Arbor Pharmaceuticals, Inc.$635
- Averitas Pharma Inc.$599
- Lundbeck LLC$599
- plus $3K from 36 others
What the payments were for
- Travel & lodging$1,05512%
- Food & beverage$7,39287%
- Education$390%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$1,062
- Intracept$691
- VYEPTI$599
- Nalu Neurostimulation System$593
- HA MINUTEMAN G3-R$411
- Qutenza$361
- GENERAL PAIN MANAGEMENT$225
- Prospera$150
- Omnia$145
- Octrode SCS Leads$133
- mild Device Kit$126
- KYPHON Balloon Kyphoplasty$115
- INTELLIS ADAPTIVESTIM$113
- QULIPTA$108
- BOTOX$103
How this compares
$8,486 in reported general payments places this provider in the 65th percentile of 180 pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 251 | $3,138 |
| Pregabalin | 84 | $2,421 |
| Duloxetine Hcl | 122 | $2,179 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 103 | $1,642 |
| Celecoxib | 42 | $1,152 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 55 | $1,118 |
| Tizanidine Hcl | 66 | $257 |
| Tramadol Hcl | 47 | $196 |
| Methylprednisolone | 28 | $148 |
| Amitriptyline Hcl | 17 | $50 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Scottsdale
- Tory McJunkinScottsdale$204K
- Vivek IyerScottsdale$70K
- Avijit SharmaScottsdale$23K
- Natalie StrandScottsdale$22K
- Jason JensenScottsdale$21K
- Matthew CrooksScottsdale$21K
- Nikesh SethScottsdale$15K
- Ashu GoyleScottsdale$10K
- Eric CornidezTucson$496K
- Minesh ZaveriPhoenix$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.